, Tracking Stock Market Picks
Enter Symbol:
Allergan Plc (AGN) [hlAlert]

Equal Weight
up 191.53 %

Actavis Inc. (ACT) rated Equal Weight with price target $250 by Barclays

Posted on: Monday,  Sep 22, 2014  12:25 PM ET by Barclays

Barclays rated Equal Weight Allergan Plc (NYSE: AGN) on 09/22/2014. Previously Barclays rated Overweight Allergan Plc (NYSE: AGN) on 05/03/2013.,
when the stock price was $107.02. Since then, Allergan Plc has gained 191.53% as of 11/24/2015's recent price of $312.00.
If you would have followed the previous Barclays's recommendation on AGN, you would have gained 191.53% of your investment in 935 days.

Watson Pharmaceuticals, Inc. (Watson) is a specialty pharmaceutical company engaged in the development, manufacture, marketing, sale and distribution of brand and generic (off-patent) pharmaceutical products. Watson operates and manages its business as three operating segments: Generic, Brand and Distribution. As of December 31, 2008, the Company marketed approximately 150 generic pharmaceutical product families and 27 brand pharmaceutical product families through its generic and brand divisions, respectively, and distributed approximately 8,000 stock-keeping units (SKUs) through its distribution division. The Company?s operations are based predominantly in the United States and India, with its key commercial market being the United States. In July 2008, Watson and Mylan Inc. announced that Mylan Inc. has acquired Watson?s 50% interest in the Somerset Pharmaceuticals, Inc. joint venture. In December 2009, the Company completed the acquisition of Arrow Group.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/22/2014 12:25 PM Buy
235.54 250.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/19/2014 3:25 PM Buy
209.28 250.00
2/3/2014 1:25 PM Buy
182.99 230.00
10/30/2013 1:25 PM Buy
156.35 190.00
9/16/2013 12:25 PM Buy
137.75 175.00
5/21/2013 12:25 PM Buy
127.89 140.00
5/3/2013 1:25 PM Buy
107.02 120.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy